South Africa saves $326 million on dolutegravir
Men accounted for two-thirds of HIV transmission in PopART prevention trial
Dolutegravir leads to weight gain in two African studies
Home tests aren’t an accurate way for people on HIV treatment to check they still have HIV
Low harm reduction coverage for people who inject drugs in South Africa
Statin therapy did not slow atherosclerosis progression in people with HIV
People with HIV express high satisfaction with monthly injectable regimen
Poorer HIV care outcomes for those using alcohol and drugs in sub-Saharan African countries
Dolutegravir recommended for all in new World Health Organization guidelines
